Quest Diagnostics Oncology sponsored ZERO Prostate Cancer as they work to educate patients throughout their prostate cancer journey during September as Prostate Cancer Awareness Month
Public source
Publisher name
Public post
September is Prostate Cancer Awareness Month, and this year we are proud to sponsor ZERO Prostate Cancer as they work to educate patients throughout their prostate cance…
Company
Quest Diagnostics Oncology
Industry-leading experience and expertise in oncology diagnostics with the broadest test menu available
- Industry
- Hospitals and Health Care
- Location
- Secaucus, US
- Company size
- 11–50 employees
About Quest Diagnostics Oncology
We are the world’s leading provider of cancer diagnostics, with the most comprehensive capabilities in anatomic pathology and molecular diagnostics. Our innovative test menu includes various options for screening, diagnosis, treatment, and monitoring recurrence.
See moreLatest activity
Latest activity from Quest Diagnostics Oncology
3 signals
Presence & Recognition
Quest Diagnostics Oncology is exhibiting at booth 204 during the College of American Pathologists (CAP) Meeting in Las Vegas on October 3–6 to explore pathology testing partnerships.
People
Quest Diagnostics Oncology is hiring an experienced Oncology sales rep in Philadelphia, PA.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
GenesisCare
GenesisCare sponsored the Private Cancer Physicians of Australia Limited (PCPA) Cancer Summit bringing together leaders and clinicians to discuss private cancer care.
Presence & Recognition
Labcorp
Labcorp supports development across every stage of oncology ahead of the World CB & CDx Summit.
Presence & Recognition
RAYUS Radiology
RAYUS Radiology recognized Prostate Cancer Awareness Month
Presence & Recognition
BioCare, Inc
BioCare, Inc recognized healthcare professionals, researchers, and advocacy organizations committed to improving outcomes and advancing innovation during Blood Cancer Awareness Month.
Partnerships
ZERO Prostate Cancer